2-Bromoacetamide → HCID 21893338, compound
Reaction equation
C[NH+]1CCOCC1.[NH2:8][C:9]1[C:14]([C:15]#[N:16])=[C:13]([C:17]2[CH:22]=[CH:21][C:20]([S:23]([N:26]3[CH2:31][CH2:30][N:29]([CH3:32])[CH2:28][CH2:27]3)(=[O:25])=[O:24])=[CH:19][CH:18]=2)[C:12]([C:33]#[N:34])=[C:11]([SH:35])[N:10]=1.Br[CH2:37][C:38]([NH2:40])=[O:39].C([O-])(O)=O.[Na+]>CN(C=O)C>[NH2:8][C:9]1[N:10]=[C:11]([S:35][CH2:37][C:38]([NH2:40])=[O:39])[C:12]([C:33]#[N:34])=[C:13]([C:17]2[CH:18]=[CH:19][C:20]([S:23]([N:26]3[CH2:31][CH2:30][N:29]([CH3:32])[CH2:28][CH2:27]3)(=[O:25])=[O:24])=[CH:21][CH:22]=2)[C:14]=1[C:15]#[N:16]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
84 mg (0.163 mmol) of 2-amino-4-{4-[(4-methylpiperazino)sulfonyl]phenyl}-6-sulfanyl-3,5-pyridinedicarbonitrile N-methylmorpholinium salt together with 53.3 mg (0.244 mmol) of bromoacetamide and 54.7 mg (0.65 mmol) of NaHCO3 are stirred in 0.5 ml of DMF overnight. After filtration, the reaction solution is initially purified by preparative HPLC. The isolated fraction is reconcentrated under reduced pressure and the residue is purified by preparative thin-layer chromatography.
Workup
- filtrationAfter filtration
- customthe reaction solution is initially purified by preparative HPLC
- customthe residue is purified by preparative thin-layer chromatography
Sources & evidence
- ORD record
- ord-0bc141917f6e47fa99fd8858c6e22bb6
- Source dataset
- uspto-grants-2006_11
- Patent number
- US07135486B1
Reaction notes
Loading…